Related references
Note: Only part of the references are listed.DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
Maria E. Figueroa et al.
CANCER CELL (2010)
Sensitive and Specific Detection of Early Gastric Cancer with DNA Methylation Analysis of Gastric Washes
Yoshiyuki Watanabe et al.
GASTROENTEROLOGY (2009)
Histone Deacetylase Inhibitors: Potential in Cancer Therapy
P. A. Marks et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Aberrant promotor methylation in MDS hematopoietic cells during in vitro lineage specific differentiation is differently associated with DNMT isoforms
Olaf Hopfer et al.
LEUKEMIA RESEARCH (2009)
Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer
Stella Tommasi et al.
BREAST CANCER RESEARCH (2009)
An analytical pipeline for genomic representations used for cytosine methylation studies
Reid F. Thompson et al.
BIOINFORMATICS (2008)
Advances in the understanding of mantle cell lymphoma
Pedro Jares et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Oncogenic NOTCH1 control of MYC and PI3K: Challenges and opportunities for anti-NOTCH1 therapy in T-cell acute lymphoblastic leukemias and lymphomas
Teresa Palomero et al.
CLINICAL CANCER RESEARCH (2008)
A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor
Nicholas C. Turner et al.
EMBO JOURNAL (2008)
PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer
J. S. Yu et al.
ONCOGENE (2008)
Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma
C. S. Chim et al.
HUMAN PATHOLOGY (2007)
Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical
Xiaobin Zhao et al.
BLOOD (2007)
Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells
Norihiko Kawamata et al.
BLOOD (2007)
Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements
Marcel W. Coolen et al.
NUCLEIC ACIDS RESEARCH (2007)
Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle cell lymphomas
Tim Ripperger et al.
HAEMATOLOGICA (2007)
Comparative isoschizomer profiling of cytosine methylation: The HELP assay
Batbayar Khulan et al.
GENOME RESEARCH (2006)
Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma
G Hutter et al.
GENES CHROMOSOMES & CANCER (2006)
Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry
M Ehrich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Pathogenesis of mantle-cell lymphoma:: All oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways
V Fernàdez et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFβ signalling pathways
EG Rizzatti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Aberrant expression of tetraspanin molecules in B-cell chronic lymphoproliferative disorders and its correlation with normal B-cell maturation
S Barrena et al.
LEUKEMIA (2005)
De novo DNA methyltransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2′-deoxycytidine
M Oka et al.
ONCOGENE (2005)
SOCS1 and SHP1 hypermethylation in mantle cell lymphoma and follicular lymphoma:: implications for epigenetic activation of the Jak/STAT pathway
CS Chim et al.
LEUKEMIA (2004)
Cyclin D1 activation in B-cell malignancy: association with changes in histone acetylation, DNA methylation, and RNA polymerase II binding to both promoter and distal sequences
H Liu et al.
BLOOD (2004)
Chromosomal instability and tumors promoted by DNA hypomethylation
A Eden et al.
SCIENCE (2003)
Induction of tumors in mice by genomic hypomethylation
F Gaudet et al.
SCIENCE (2003)
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
A Rosenwald et al.
CANCER CELL (2003)
Automated subcellular localization and quantification of protein expression in tissue microarrays
RL Camp et al.
NATURE MEDICINE (2002)
DNA methylation in cancer: too much, but also too little
M Ehrlich
ONCOGENE (2002)
Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia
S Mizuno et al.
BLOOD (2001)
Targeted inactivation of the tetraspanin CD37 impairs T-cell-dependent B-cell response under suboptimal costimulatory conditions
KP Knobeloch et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
